Clinical trials recruiting for Squamous Non-Small Cell Lung Cancer (NSCLC)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cyclophosphamide | 1 |
| Fludarabine | 1 |
| HDM2020 (FGFR2b-ADC) | 1 |
| ZI-MA4-1 (TCR-NK cells) | 1 |
| [177Lu]Lu-DPI-4452 | 1 |
| [68Ga]Ga-DPI-4452 | 1 |
Self-screener
Recruiting trials
- A Study of HDM2020 in Patients With Advanced Sq-NSCLC
- A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies
Related conditions
Trials recruiting for Squamous Non-Small Cell Lung Cancer (NSCLC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Squamous Non-Small Cell Lung Cancer (NSCLC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.